FDAmanufacturing / CMC65% confidence
Developing and Manufacturing Drugs Including Biologics
Source: FDA
Why This Matters
Why this matters: provides agency context on manufacturing / CMC that may shape timing or evidence expectations for Roche.
Regulatory Analysis
This material is intended to be a helpful resource that consolidates information relevant for drug manufacturers making products for the U.S. It is not a comprehensive list of all applicable statutory and regulatory requirements.
Supporting Context
- Therapeutic area
- Neurology · Alzheimer's Disease
- Sub-indication
- General
Related signal: Roche's Elecsys® pTau217 Blood Test Receives CE Mark for Alzheimer's Diagnosis